Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nucleic Acid Binding Molecules.

Current protocols in nucleic acid chemistry·2022
Same author

Novel, Self-Assembling Dimeric Inhibitors of Human β Tryptase.

Journal of medicinal chemistry·2020
Same author

A Novel, Nonpeptidic, Orally Active Bivalent Inhibitor of Human β-Tryptase.

Pharmacology·2018
Same author

Target-Directed Self-Assembly of Homodimeric Drugs Against β-Tryptase.

ACS medicinal chemistry letters·2018
Same author

DNA Three-Way Junctions Stabilized by Hydrophobic Interactions for Creation of Functional Nanostructures.

Chembiochem : a European journal of chemical biology·2015
Same author

Reversible linkage of two distinct small molecule inhibitors of Myc generates a dimeric inhibitor with improved potency that is active in myc over-expressing cancer cell lines.

PloS one·2015

Related Experiment Video

Updated: May 23, 2026

DNAzyme 10-23 - Based Nanomachines for Nucleic Acid Recognition
07:16

DNAzyme 10-23 - Based Nanomachines for Nucleic Acid Recognition

Published on: February 9, 2024

Evaluation of end-capped DNA modules for pRNA capture and functionalization.

Brian M Laing1, Donald E Bergstrom

  • 1Department of Medicinal Chemistry and Molecular Pharmacology and Bindley Bioscience Center, Purdue University, West Lafayette, Indiana 47907, USA.

Bioconjugate Chemistry
|March 27, 2012
PubMed
Summary

Researchers developed a method using DNA segments to attach molecules to packaging RNA (pRNA) for nanomedicine applications. This technique enables precise functionalization of RNA nanostructures for targeted drug delivery and diagnostics.

More Related Videos

DNA-Tethered RNA Polymerase for Programmable In vitro Transcription and Molecular Computation
09:26

DNA-Tethered RNA Polymerase for Programmable In vitro Transcription and Molecular Computation

Published on: December 29, 2021

Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids
09:04

Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids

Published on: September 21, 2017

Related Experiment Videos

Last Updated: May 23, 2026

DNAzyme 10-23 - Based Nanomachines for Nucleic Acid Recognition
07:16

DNAzyme 10-23 - Based Nanomachines for Nucleic Acid Recognition

Published on: February 9, 2024

DNA-Tethered RNA Polymerase for Programmable In vitro Transcription and Molecular Computation
09:26

DNA-Tethered RNA Polymerase for Programmable In vitro Transcription and Molecular Computation

Published on: December 29, 2021

Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids
09:04

Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids

Published on: September 21, 2017

Area of Science:

  • RNA nanotechnology
  • Nanomedicine
  • Molecular biology

Background:

  • Packaging RNA (pRNA) from the phi29 DNA packaging motor self-assembles into nanostructures.
  • These RNA nanostructures are promising for nanomedicine applications.
  • Functionalization of pRNA is required for attaching active molecules in nanomedicine.

Purpose of the Study:

  • To investigate end-capped double-stranded DNA segments as reversible capture reagents for pRNA.
  • To develop a method for conjugating active molecules to pRNA for nanomedicine.

Main Methods:

  • Designed end-capped double-stranded DNA segments with specific overhangs.
  • Investigated the association of these DNA segments with pRNA.
  • Model studies were conducted to evaluate the efficiency of the capture agents.

Main Results:

  • End-capped double-stranded DNA segments act as effective capture reagents for pRNA.
  • 5- to 7-nucleotide overhangs on pRNA facilitate high-affinity association with the DNA capture agents.
  • This method allows for the conjugation of desired molecules for pRNA functionalization.

Conclusions:

  • Developed a novel strategy for functionalizing pRNA using DNA capture agents.
  • This approach enables precise modification of RNA nanostructures for nanomedicine.
  • The method offers a versatile platform for creating targeted RNA-based nanodevices.